EMISPHERE ACHIEVES SECOND MILESTONE IN ROCHE COLLABORATION

Emisphere Technologies, Inc. announced today that it has achieved a second milestone under its November 2004 agreement with Roche to develop new oral formulations of a Roche small molecule compound for the treatment of bone-related diseases. The achievement of this milestone, resulting in an undisclosed payment from Roche, arises from Roche's initiation of a clinical study utilizing Emisphere's eligen(R) delivery technology in a formulation for a second product.
Drug Newswire